Format

Send to

Choose Destination
Vaccine. 2020 Apr 3;38(16):3179-3183. doi: 10.1016/j.vaccine.2020.02.038. Epub 2020 Mar 12.

Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness.

Author information

1
Public Health Consultant, USA. Electronic address: brucearuscio@gmail.com.
2
Task Force for Global Health, Inc, USA.
3
Centers for Disease Control and Prevention, Atlanta, GA, USA.
4
Sanofi Pasteur, Lyon, France.
5
GSK, Wavre, Belgium.
6
UNICEF, Denmark.
7
Coalition for Epidemic Preparedness Innovations, Oslo, Norway.
8
BU Biologics, Cadila Healthcare Ltd.(Zydus Cadila), Ahmedabad, India.
9
Sabin Vaccine Institute, Washington, DC, USA.
10
Wellcome, London, UK.
11
London School of Hygiene & Tropical Medicine, London, United Kingdom; Public Health England, London, United Kingdom; University of Hong Kong, Hong Kong Special Administrative Region.
12
Health and Human Services, Washington, DC, USA.
13
Sinergium Biotech S.A, Argentina.
14
Gavi, the Vaccine Alliance, Switzerland.
15
Seqirus, Summit, NJ, USA.
16
Developing Countries Vaccine Manufacturers Network (DCVMN) International, Nyon, Switzerland.
17
European Centre for Disease Prevention and Control (ECDC), Sweden.
18
Pan American Health Organization/World Health Organization, USA.
19
U.S. Department of State, Washington, DC, USA.
20
ODI, London, UK.
21
Hong Kong Polytechnic University, Hong Kong.
22
Seqirus Vaccines, Liverpool, UK.
23
Vaccines For All, Pune, India.
24
Public Health England, London, United Kingdom.
25
National Immunization Program, Ministry of Health, Lao Democratic People's Republic.

Abstract

In March 2019, a group of global health leaders with expertise in influenza, vaccinology and pandemic preparedness was convened for a meeting titled "Shaping Meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness." Influenza epidemics occur annually in every country in the world, resulting in significant global burden of illness and deaths. While every country is effected, most deaths and severe disease occur in low- and lower middle-income countries (LIC and LMIC). Influenza immunization programs that limit the burden of disease, deaths, and reduce economic impact are a fundamental public health intervention for seasonal epidemics. In addition, they provide the experience, systems and infrastructure for the timely and efficient use of vaccines and other medical countermeasures critical for effective pandemic responses. Pandemic influenza response activities, including vaccination efforts, will be most effective if used and practiced regularly. Consequently, countries with seasonal influenza prevention and control programs should be better prepared for, and have more effective pandemic responses than countries without such programs. A decade after the 2009 pandemic, despite ongoing prevention efforts, most LICs and LMICs still lack access to robust seasonal influenza immunization programs. Given this current state, meeting participants concluded that there is critical need to advance the expansion and strengthening of seasonal influenza immunization programs in LICs and LMICs not only to reduce the economic and public health effects of annual influenza epidemics, but also to increase preparedness to mitigate the threat of future pandemics and improve global heath security. Many government and private sectors, in a whole of government approach, need to be working together to support and advance countries' epidemic and pandemic influenza capacities preparedness objectives. Accomplishment of these objectives can be achieved with a coordinated work plan developed and guided by an alliance of international stakeholders, to include, among others, government, and nongovernment organization representation, civil society representatives, vaccine manufacturers, international organizations, and health security and influenza experts.

KEYWORDS:

Health security; Immunization; Influenza vaccine; Pandemic influenza; Pandemic preparedness; Policy; Seasonal influenza

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center